Skip to content

N99 Face Mask Spectra Shield 9900 (28 Day Reusable) Antimicrobial Respirator Protective

Save 66%
Original price $87.00
Current price $29.95

SpectraShield™ 9900 is the only N99 face mask proven to continuously kill bacteria and fight microorganism contamination with filtration superior to N95 masks. Now available in Canada, the SpectraShield™ 9900 is intended to be used as a front line defense against infectious and contagious diseases.

"Results from the studies showed that SpectraShield™ 9900 respirator mask inactivates a broad spectrum of bacteria capable of airborne transmission to levels below detection within one hour, and in some instances less than 10 minutes, and also exhibits anti-viral activity," said Dr. Gerba.

With tested filtration performance equivalent to an N99 (meaning 99% of contaminants are trapped in the filter and do not penetrate the mask), the SpectraShield™ 9900 mask exceeds the United States Center for Disease Control and World Health Organization guidelines for protection against infectious microbial threats such as Avian Influenza, SARS and Tuberculosis.

SpectraShield Respirator Mask Specifications:

SpectraShield™ 9900 is manufactured using a patented technology; antimicrobial fibers used in the mask incorporate a non-toxic silver-copper ionic agents proven safe for extended contact with individuals. Due to SpectraShield™ 9900's antimicrobial properties, odor caused by bacterial growth is also eliminated.

Study: Studies, conducted over the past year, were designed to evaluate the mask's antimicrobial properties on a number of bacterial microorganisms including Escherichia coli, streptococcus pyogenes, methicillin resistant staphylococcus aureus, legionella pneumophila, haemophilus influenza, and coliphage MS-2. Varying inoculation concentrations of 0 to 1,000,000 units were tested within a time span of 0 - 60 minutes. Results indicated that 99.99 to 99.999% (or to five log reduction) of the bacterial microorganisms were killed within one hour. More extensive evaluation studies are also underway for viral microorganisms.

About Nexera Medical Ltd.
Nexera Medical Ltd., a wholly owned subsidiary of Nexera Medical Inc., is engaged in the development, manufacturing and distribution of antimicrobial respirator and surgical masks, as well as other antimicrobial textile based medical products such as medical slings, surgical site aprons and hospital linen products worldwide. The company's mission is to create high-quality, cutting-edge health related medical products designed to safeguard and enhance the quality of human life. All of Nexera's products are designed to provide maximum protection against microorganisms such as bacteria, virus and fungus using Fosshield® patented technology. Nexera partners with governments and leaders in the health care industry in the fight against viral pandemic and other healthcare crises. For more information, visit www.nexeramed.com.

Disclaimer: On February 29, 2020, CDC published guidance strategies for optimizing the supply of N95 respirators to help prevent the spread of bacterial and viruses. This guidance provides Crisis Alternate Strategies that includes the option to "use of medical grade respirators approved under standards used in other countries that are similar to NIOSH-approved N95 respirators." Respirators, such as an N99, N95, PFF2(s), 3-Ply, KN95 and surgical masks, are designed to protect the wearer from inhaling or spreading airborne bacteria or virus particles.